Steven P. Gelone is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 14,283 shares of NBRV, which is worth approximately $5,713. The most recent transaction as insider was on Jan 31, 2021, when has been sold 75 shares (Ordinary Shares) at a price of $2.62 per share, resulting in proceeds of $196. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K
0% 3M change
0% 12M change
Total Value Held $5,713

Steven P. Gelone Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2021
SELL
Payment of exercise price or tax liability
$196 $2.62 p/Share
75 Reduced 0.1%
78,154 Ordinary Shares
Jan 29 2021
BUY
Grant, award, or other acquisition
-
42,500 Added 35.2%
78,229 Ordinary Shares
Dec 31 2020
SELL
Payment of exercise price or tax liability
$152 $2.42 p/Share
63 Reduced 0.18%
35,729 Ordinary Shares
Nov 30 2020
SELL
Payment of exercise price or tax liability
$270 $0.43 p/Share
628 Reduced 0.18%
357,926 Ordinary Shares
Oct 31 2020
SELL
Payment of exercise price or tax liability
$314 $0.5 p/Share
628 Reduced 0.17%
358,554 Ordinary Shares
Sep 30 2020
SELL
Payment of exercise price or tax liability
$333 $0.53 p/Share
628 Reduced 0.17%
359,182 Ordinary Shares
SPG

Steven P. Gelone

Director
Fort Washington, PA

Track Institutional and Insider Activities on NBRV

Follow Nabriva Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

News

Receive news related to Nabriva Therapeutics plc

Track Activities on NBRV